Intervention not reported
Typical antipsychoticvs atypical antipsychotic · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Statin (HMG‐CoA) vs placebo · critically ill adults with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Alpha2 agonist vs typical antipsychotic · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Alpha2 agonist vs 5HT3 inhibitor · critically ill adult with confirmed or at high risk of delirium
The intervention led to lower alpha2 agonist vs 5HT3 inhibitor; GRADE not reported.
1 finding from 1 review
Intervention not reported
Alpha2 agonist vs placebo · critically ill adults with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Cholinesterase inhibitor vs placebo · critically ill adults with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Opioid vs placebo · critically ill adults with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Typical antipsychotic vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Atypical antipsychotic vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
Statin (HMG‐CoA) vs placebo · critically ill adult with confirmed or at high risk of delirium
1 finding from 1 review
Intervention not reported
All‐cause mortality · newborn infants at risk of gastrointestinal bleeding
It is very uncertain whether the intervention changes all‐cause mortality (very low certainty).
1 finding from 1 review
Intervention not reported
Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding · newborn infants at risk of gastrointestinal bleeding
The intervention probably leads to lower any upper gastrointestinal bleeding in infants at risk of upper… (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · infants with upper gastrointestinal bleeding
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
Duration of upper gastrointestinal bleeding (days) · infants with upper gastrointestinal bleeding
1 finding from 1 review
Intervention not reported
Continued upper gastrointestinal bleeding · infants with upper gastrointestinal bleeding
The intervention may leads to lower continued upper gastrointestinal bleeding (low certainty).
1 finding from 1 review
Intervention not reported
Anaemia requiring blood transfusion · infants with upper gastrointestinal bleeding
The intervention showed no clear difference in anaemia requiring blood transfusion (low certainty).
1 finding from 1 review
Acute postoperative pain 0 to 6 hours (Score 0 to 10, VAS or NRS Scale) · adults undergoing brain surgery
1 finding from 1 review
Length of hospital stay · adults undergoing brain surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event nausea and vomiting (0 to 24 hours) · adults undergoing brain surgery
Nonsteroidal anti‐inflammatory drugs (NSAIDs) showed no clear difference in adverse event nausea and vomiting (0 to 24 hours) compared with control or placebo medications (low certainty).
1 finding from 1 review
Acute postoperative pain 0 to 6 hours (Score 0 to 10, VAS or NRS Scale) · adults undergoing brain surgery
1 finding from 1 review